{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:24:13Z","timestamp":1791429853115,"version":"4.3.3"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7232115"],"award-info":[{"award-number":["7232115"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences &amp; Peking Union Medical College","doi-asserted-by":"publisher","award":["2022-PUMCH-A-138"],"award-info":[{"award-number":["2022-PUMCH-A-138"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytica Chimica Acta"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.aca.2025.344403","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T07:52:23Z","timestamp":1752565943000},"page":"344403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Enzymatic hydrolysis combined with chemiluminescence immunoassay: Foresight for automated and rapid urinary aldosterone detection"],"prefix":"10.1016","volume":"1371","author":[{"given":"Jian","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0734-8144","authenticated-orcid":false,"given":"Ling","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aca.2025.344403_bib1","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary aldosteronism in patients in China with recently detected hypertension","volume":"75","author":"Xu","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.aca.2025.344403_bib2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamasurg.2021.0254","article-title":"Outcomes of a specialized clinic on rates of investigation and treatment of primary aldosteronism","volume":"156","author":"Liu","year":"2021","journal-title":"JAMA Surg."},{"key":"10.1016\/j.aca.2025.344403_bib3","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.aca.2025.344403_bib4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","article-title":"Primary aldosteronism-a multidimensional syndrome","volume":"18","author":"Turcu","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.aca.2025.344403_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S2213-8587(17)30368-6","article-title":"Primary aldosteronism and cardiovascular risk, before and after treatment","volume":"6","author":"Funder","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.aca.2025.344403_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/cvr\/cvac027","article-title":"Aldosterone and cardiovascular diseases","volume":"119","author":"Parksook","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.aca.2025.344403_bib7","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/HYPERTENSIONAHA.121.18342","article-title":"Higher plasma aldosterone concentrations are associated with elevated risk of aortic dissection and aneurysm: a case-control study","volume":"79","author":"Zhu","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.aca.2025.344403_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2018.5842","article-title":"Clinical outcomes after unilateral adrenalectomy for primary aldosteronism","volume":"154","author":"Vorselaars","year":"2019","journal-title":"JAMA Surg."},{"key":"10.1016\/j.aca.2025.344403_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120186","article-title":"Unmasking primary aldosteronism: transforming disease management with advanced steroid profiling","volume":"570","author":"Zhong","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.aca.2025.344403_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.ajkd.2023.01.447","article-title":"Underdiagnosis of primary aldosteronism: a review of screening and detection","volume":"82","author":"Funes Hernandez","year":"2023","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.aca.2025.344403_bib11","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.aca.2025.344403_bib12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","article-title":"Intraindividual variability of aldosterone concentrations in primary aldosteronism: implications for case detection","volume":"77","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.aca.2025.344403_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/clinem\/dgac568","article-title":"Aldosterone, renin, and aldosterone-to-renin ratio variability in screening for primary aldosteronism","volume":"108","author":"Ng","year":"2023","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.aca.2025.344403_bib14","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/jc.2002-021476","article-title":"Variability in the renin\/aldosterone profile under random and standardized sampling conditions in primary aldosteronism","volume":"88","author":"Tanabe","year":"2003","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.aca.2025.344403_bib15","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/clinem\/dgac679","article-title":"Intra-individual variability of serum aldosterone and implications for primary aldosteronism screening","volume":"108","author":"Maciel","year":"2023","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.aca.2025.344403_bib16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1210\/jcem-52-2-214","article-title":"Urinary tetrahydroaldosterone and aldosterone-18-glucuronide excretion in white and Black normal subjects and hypertensive patients","volume":"52","author":"Gomez-Sanchez","year":"1981","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.aca.2025.344403_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0002-9378(82)90389-1","article-title":"Urinary free 18-hydroxycorticosterone, plasma aldosterone, and urinary aldosterone metabolites in normal pregnancy","volume":"144","author":"Bauknecht","year":"1982","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.aca.2025.344403_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/cs0570409","article-title":"Dissociation in the excretion of different aldosterone metabolites and unmetabolized ('free') aldosterone in hypertension","volume":"57","author":"Abdelhamid","year":"1979","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.aca.2025.344403_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jchromb.2019.03.012","article-title":"Establishment of a rapid and simple liquid chromatography tandem mass spectrometry method for measuring aldosterone in urine","volume":"1113","author":"Yin","year":"2019","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.aca.2025.344403_bib20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/clinchem\/hvad065","article-title":"A novel enzymatic hydrolysis method for urine aldosterone quantification: a case for reassessing clinical cut-offs of primary aldosteronism","volume":"69","author":"Yazdanpanah","year":"2023","journal-title":"Clin. Chem."},{"key":"10.1016\/j.aca.2025.344403_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/INMD.20240077","article-title":"Establishing a liquid chromatography\u2010tandem mass spectrometry (LC\u2010MS\/MS) method for both 18\u2010hydroxycorticosterone and its interference: revisiting the specificity characteristic of LC\u2010MS\/MS in the steroid measurement","author":"Yu","year":"2025","journal-title":"Interdiscipl. Med."},{"key":"10.1016\/j.aca.2025.344403_bib22","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1515\/cclm-2016-0841","article-title":"Evaluation of a chemiluminescent immunoassay for urinary aldosterone on the DiaSorin LIAISON automated platform against RIA and LC-MS\/MS","volume":"55","author":"Lin","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.aca.2025.344403_bib24","author":"Laboratories"},{"key":"10.1016\/j.aca.2025.344403_bib25","series-title":"User Verification of Precision and Estimation of Bias","first-page":"12","author":"Institute","year":"2014"},{"key":"10.1016\/j.aca.2025.344403_bib26","series-title":"CLSI Document EP17-A2. Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures; Approved Guideline","year":"2012"},{"key":"10.1016\/j.aca.2025.344403_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.859347","article-title":"Re-Assessment of the oral salt loading test using a new chemiluminescent enzyme immunoassay based on a two-step sandwich method to measure 24-Hour urine aldosterone excretion","volume":"13","author":"Ozeki","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.aca.2025.344403_bib29","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1515\/cclm-2023-0250","article-title":"A novel LC-MS\/MS-based assay for the simultaneous quantification of aldosterone-related steroids in human urine","volume":"62","author":"Vogg","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.aca.2025.344403_bib30","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae080","article-title":"Screening cutoff values for the detection of aldosterone-producing adenoma by LC-MS\/MS and a novel noncompetitive CLEIA","volume":"8","author":"Ono","year":"2024","journal-title":"J. Endoc. Soc."},{"key":"10.1016\/j.aca.2025.344403_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11030433","article-title":"Development of a new chemiluminescent enzyme immunoassay using a two-step sandwich method for measuring aldosterone concentrations","volume":"11","author":"Ozeki","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.aca.2025.344403_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120356","article-title":"Development and evaluation of a novel non-competitive MAGLUMI estradiol chemiluminescence immunoassay","volume":"575","author":"Wang","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.aca.2025.344403_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clinbiochem.2015.11.004","article-title":"Sodium interference in the determination of urinary aldosterone","volume":"49","author":"Aldea","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.aca.2025.344403_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124012","article-title":"A LC-MS\/MS method for the simultaneous quantitative determination of aldosterone, its precursor 18-hydroxycorticosterone and its metabolite tetrahydroaldosterone in human urine","volume":"1234","author":"Dong","year":"2024","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.aca.2025.344403_bib35","first-page":"63","article-title":"Urine aldosterone and urine aldosterone-to-active-renin ratio in the diagnosis of primary aldosteron","volume":"22","author":"Zeng","year":"2014","journal-title":"Chin. J. Hypertens."},{"key":"10.1016\/j.aca.2025.344403_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism","volume":"173","author":"Brown","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.aca.2025.344403_bib37","first-page":"4125","article-title":"Value of 24-hour urinary aldosterone in diagnosis and classification of primary hyperaldosteronism","volume":"104","author":"Zhang","year":"2024","journal-title":"Zhonghua Yixue Zazhi"},{"key":"10.1016\/j.aca.2025.344403_bib38","first-page":"261","article-title":"Clinical utility value of urinary aldosterone detection by tandem mass spectrometry in primary hyperaldosteronism screening","volume":"43","author":"Ma","year":"2020","journal-title":"Chin. J. Lab. Med."},{"key":"10.1016\/j.aca.2025.344403_bib39","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1210\/en.2002-0052","article-title":"Human uridine diphosphate-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites","volume":"144","author":"Girard","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.aca.2025.344403_bib40","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-59-1-1","article-title":"Observations on metabolism of aldosterone in man","volume":"59","author":"Luetscher","year":"1963","journal-title":"Ann. Intern. Med."}],"container-title":["Analytica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267025007974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267025007974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:17:39Z","timestamp":1777457859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003267025007974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":38,"alternative-id":["S0003267025007974"],"URL":"https:\/\/doi.org\/10.1016\/j.aca.2025.344403","relation":{},"ISSN":["0003-2670"],"issn-type":[{"value":"0003-2670","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enzymatic hydrolysis combined with chemiluminescence immunoassay: Foresight for automated and rapid urinary aldosterone detection","name":"articletitle","label":"Article Title"},{"value":"Analytica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aca.2025.344403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"344403"}}